The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia

Human Immunology

Volumn 75, Issue 2, 2014, Pages 113-118

  Sun, Yuan xin ^a   Kong, Hai li ^b   Liu, Chuan fang ^a   Yu, Shuang ^a   Tian, Tian ^a   Ma, Dao xin ^a   Ji, Chun yan ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; THROMBOCYTE COUNT; TUMOR MICROENVIRONMENT; YOUNG ADULT; ADOLESCENT; BONE MARROW CELL; CARCINOGENESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HELPER CELL; IMMUNOLOGY; METABOLISM; TH1 TH2 BALANCE;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; CARCINOGENESIS; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE; YOUNG ADULT;

EID: 84892371343     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.11.014     Document Type: Article

References (43)

1. Szczepanski M.J., Szajnik M., Czystowska M., Mandapathil M., Strauss L., Welsh A., et al. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res 2009, 15:3325.
2. Wu C., Wang S., Wang F., Chen Q., Peng S., Zhang Y., et al. Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukemia. Clin Exp Immunol 2009, 158:199.
3. Parovichnikova E.N., Gal'tseva I.V., Vorob'ev I.A., Savchenko V.G. Characteristics of T-cell immunity in patients with acute leukemia. Ter Arkh 2006, 78:18.
4. Buggins A.G., Milojkovic D., Arno M.J., Lea N.C., Mufti G.J., Thomas N.S., et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 2001, 167:6021.
5. Panitsas F.P., Theodoropoulou M., Kouraklis A., Karakantza M., Theodorou G.L., Zoumbos N.C., et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004, 103:2645.
6. Jones E.A., Pringle J.H., Angel C.A., Rees R.C. Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL). Leuk Lymphoma 2002, 43:1313.
7. Hamdi W., Ogawara H., Handa H., Tsukamoto N., Murakami H. Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome. Int J Lab Hematol 2009, 31:630.
8. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051.
9. Schwarzenberger P., Kolls J.K. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem Suppl 2002, 38:88.
10. Jäger A., Kuchroo V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 2010, 72:173.
11. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566.
12. Zhang L., Li J.-m., Liu X.-g., Ma D.-x., Hu N.-w., Li Y.-g., et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011, 31:606.
13. Hu Y., Li H., Zhang L., Shan B., Xu X., Liu X., et al. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Hum Immunol 2012, 73:629.
14. Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev 2010, 21:435.
15. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937.
16. Cheson B.D., Bennett J.M., Kopecky K.J., Buchner T., Willman C.L., Estey E.H., et al. Revised recommendations of the International Working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003, 21:4642.
17. Milojkovic D., Devereux S., Westwood N.B., Mufti G.J., Thomas N.S., Buggins A.G. Antiapoptotic microenvironment of acute myeloid leukemia. J Immunol 2004, 173:6745.
18. Tato C.M.C.D. Alternative lifestyles of T cells. Nat Immunol 2008, 9:1323.
19. Reikvam H., Hatfield K.J., Fredly H., Nepstad I., Mosevoll K.A., Bruserud O. The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation. Eur Cytokine Netw 2012, 23:140.
20. Reikvam H., Mosevoll K.A., Melve G.K., Gunther C.C., Sjo M., Bentsen P.T., et al. The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of post-transplantation complications. Biol Blood Marrow Transplant 2012, 18:190.
21. Orleans-Lindsay J.K., Barber L.D., Prentice H.G., Lowdell M.W. Acute myeloid leukemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function-implications for the adoptive immunotherapy of leukemia. Clin Exp Immunol 2001, 126:403.
22. Zhu J., Paul W.E. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 2010, 238:247.
23. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005, 6:331.
24. Chaturvedi V., Collison L.W., Guy C.S., Workman C.J., Vignali D.A.A. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011, 186:6661.
25. Niedbala W., Wei X.-q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021.
26. Wang X., Zheng J., Liu J., Yao J., He Y., Li X., et al. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol 2005, 75:468.
27. Wu H., Li P., Shao N., Ma J., Ji M., Sun X., et al. Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-beta in acute myeloid leukemia. Oncol Lett 2012, 3:1119.
28. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65.
29. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999, 42:963.
30. Yamada Y., Saito H., Ikeguchi M. Prevalence and clinical relevance of Th17 cells in patients with gastric cancer. J Surg Res 2012, 178:685.
31. Li P., Ji M., Park J., Bunting K.D., Ji C., Tse W. Th17 related cytokines in acute myeloid leukemia. Front Biosci 2012, 17:2284.
32. Burgler S., Ouaked N., Bassin C., Basinski T.M., Mantel P.-Y., Siegmund K., et al. Differentiation and functional analysis of human TH17 cells. J Allergy Clin Immunol 2009, 123:588.
33. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231.
34. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484.
35. Ersvaer E., Liseth K., Skavland J., Gjertsen B.T., Bruserud O. Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17, and TREG cells. BMC Immunol 2010, 11:38.
36. Fredly H., Reikvam H., Gjertsen B.T., Bruserud O. Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment. Am J Hematol 2012, 87:368.
37. van der Schoot C.E., Jansen P., Poorter M., Wester M.R., von dem Borne A.E., Aarden L.A., et al. Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood 1989, 74:2081.
38. Testa U., Masciulli R., Tritarelli E., Pustorino R., Mariani G., Martucci R., et al. Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol 1993, 150:2418.
39. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480.
40. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin Immunopathol 2010, 32:17.
41. Jiang R., Tan Z., Deng L., Chen Y., Xia Y., Gao Y., et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011, 54:900.
42. Gangemi S., Allegra A., Alonci A., Pace E., Cannavo A., Ferraro M., et al. Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia. Blood Cells Mol Dis 2013, 50:39.
43. Zhang W., Chen Y., Wei H., Zheng C., Sun R., Zhang J., et al. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 2008, 14:6432.